All News

Found 16,367 articles

• MonoSolRx LLC Announces The Hiring Of Alexander Mark Schobel From Novartis Consumer Health, Inc. As Its New President And CEO, And The Relocation Of The Company's Headquarters To New Jersey

  12/19/2005

• The Day In Review: Novartis Corporation May Add To Vaccine Franchise

  12/19/2005

• Additional Phase 2 Data Supports Further Development Of Tanox, Inc.'s Novel HIV Therapy

  12/19/2005

• IVAX Corporation Receives Final Approval On Clozapine Tablet

  12/19/2005

• Novartis Pharmaceuticals Corporation Release: Single-Day Famvir Treatment Found To Shorten The Duration Of Recurrent Genital Herpes Outbreaks

  12/19/2005

• Novartis Corporation Halts Cholesterol Drug Development

  12/16/2005

• The Day In Review: Novartis Corporation Dumps Statin Drug Development

  12/16/2005

• Sosei Co., Ltd. Business Update And Revised Financial Forecast Following Acquisition Of Arakis Ltd.

  12/16/2005

• George A. Scangos, Ph.D., Named Chairman Of The Board Of Anadys Pharmaceuticals, Inc.

  12/16/2005

• Dr. Judith A. Hemberger Appointed To Myogen Board Of Directors

  12/16/2005

• Santhera Pharmaceuticals AG Starts European Phase III Study With Its Lead Compound SNT-MC17 In Friedreich's Ataxia

  12/15/2005

• Saegis Pharmaceuticals, Inc. Completes Phase IIa Clinical Study Of SGS518

  12/15/2005

• As Sanofi-Aventis (France) Calls Its Trial On Bird Flu Vaccine Promising, Healthcare Industry Today Offers Extended News Coverage

  12/15/2005

• Idenix Pharmaceuticals, Inc. Release: Partial 24-Week Data Demonstrate Valopicitabine (NM283) Combined With Pegylated Interferon Continues To Produce Greater Viral Suppression In Hepatitis C Treatment-Refractory Patients Compared To Retreatment With Ribav

  12/14/2005

• Anadys Pharmaceuticals, Inc. Selects A Novel Oral Toll-Like Receptor Ligand As Drug Development Candidate For Cancer

  12/14/2005

• QLT Inc. Announces Partial Result In Eligard(R) Patent Litigation

  12/14/2005

• QLT Inc. Announces TSX Approval To Increase Its Share Repurchase Program To $100 million

  12/14/2005

• Novartis Oncology Release: New Clinical Data Show Dramatic Benefits Of Femara(R) For Women With Breast Cancer Even After Prolonged Period Of No Anti-Cancer Treatment

  12/13/2005

• Stopping Tamoxifen May Help Breast Cancer

  12/12/2005

• Caraco Pharmaceutical Laboratories, Ltd. Receives FDA Approval For Carbamazepine Tablets USP

  12/12/2005